AZN AstraZeneca Plc

44.58-0.83 (-1.83%)
Close: August 23, 2019

Quote

Previous Close
$44.58
Day Range
$44.50-$45.67
52 Week Range
$35.30-$45.69
Volume
3,752,242
Avg Volume
3,643,243
Dividend TTM
$1.37 (3.07%)
Ex-Dividend Date
2019-08-08

Valuation

Market Cap
-
Enterprise Value (EV)
$132.58B
PE Ratio
51.79
EV/EBITDA
28.78
Price/Sales
5.40
Price/Book
9.38
PEG Ratio
8.93

Financials

Revenue
$22.05B
Gross Profit
$15.83B
EBITDA
$4.61B
EPS, ttm
$0.86
Profit Margin
9.76%
Revenue/Employee
$342.43K
Next Earnings Date
10/24/2019 (60 days)
Debt to Equity
153%
Debt
$138.26B
Cash
$5.68B
Net Debt
$132.58B

Performance

Beta
0.44
200 Day Moving Avg
$39.97
50 Day Moving Avg
$42.31
52 Week Change
16.40%
YTD Change
16.11%
1 Month Change
10.48%
3 Month Change
14.25%
6 Month Change
7.42%
1 Year Change
16.40%
2 Year Change
26.86%
5 Year Change
-2.07%

Share Count

Shares Outstanding
-

AstraZeneca Plc Company Details

Sector: Health Technology

Industry: Pharmaceuticals: Major

CEO: Pascal Soriot

Website: http://astrazeneca.com

Description: AstraZeneca Plc is a holding company, which engages in the research, development and manufacturing of pharmaceutical products. The company produces and commercializes medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology, and infectious diseases. Its pipeline consists of azd 4831, azd 8601, medi 6012, tagrisso bloom, durvalumab, selumetinib, lyparza polo, epanova, farxiga and brilinta. The company distributes its products under the following brands: Atacand, Crestor, Onglyza, Nexium, Entocort, Losec, Merrem/Meronem, Carbocaine, Citanest, Diprivan, Marcaine/Sensorcaine. AstraZeneca was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Employees: 64,400